000			01949 a2200565 4500
005			20250518013020.0
264		0	_c20200721
008			202007s 0 0 eng d
022			_a1582-4934
024	7		_a10.1111/jcmm.14074 _2doi
040			_aNLM _beng _cNLM
100	1		_aSchilter, Heidi
245	0	0	_aThe lysyl oxidase like 2/3 enzymatic inhibitor, PXS-5153A, reduces crosslinks and ameliorates fibrosis. _h[electronic resource]
260			_bJournal of cellular and molecular medicine _c03 2019
300			_a1759-1770 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAmino Acid Oxidoreductases _xantagonists & inhibitors
650	0	4	_aAnimals
650	0	4	_aCarbon Tetrachloride _xtoxicity
650	0	4	_aCollagen _xantagonists & inhibitors
650	0	4	_aCross-Linking Reagents _xchemistry
650	0	4	_aElastin _xantagonists & inhibitors
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aExtracellular Matrix _xdrug effects
650	0	4	_aFibrosis _xchemically induced
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Inbred C57BL
650	0	4	_aMyocardial Infarction _xenzymology
650	0	4	_aNon-alcoholic Fatty Liver Disease _xenzymology
650	0	4	_aRats
650	0	4	_aRats, Wistar
700	1		_aFindlay, Alison D
700	1		_aPerryman, Lara
700	1		_aYow, Tin T
700	1		_aMoses, Joshua
700	1		_aZahoor, Amna
700	1		_aTurner, Craig I
700	1		_aDeodhar, Mandar
700	1		_aFoot, Jonathan S
700	1		_aZhou, Wenbin
700	1		_aGreco, Angelique
700	1		_aJoshi, Amar
700	1		_aRayner, Benjamin
700	1		_aTownsend, Sarah
700	1		_aBuson, Alberto
700	1		_aJarolimek, Wolfgang
773	0		_tJournal of cellular and molecular medicine _gvol. 23 _gno. 3 _gp. 1759-1770
856	4	0	_uhttps://doi.org/10.1111/jcmm.14074 _zAvailable from publisher's website
999			_c29149726 _d29149726